Paediatric cough, cold and allergy remedies is expected to see a further strong decline in retail volume and current value sales over 2021, albeit slower than in 2020. The performance of this category is a direct consequence of Coronavirus (COVID-19). Home seclusion, limited social interaction and the wearing of face masks reduced the potential for contracting and passing on coughs, colds and flu in 2020. While the resumption of pre-pandemic lifestyles, including the return to work, schools and...

Euromonitor International’s Paediatric Consumer Health in Serbia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments , Paediatric Analgesics , Paediatric Cough, Cold and Allergy Remedies , Paediatric Dermatologicals , Paediatric Digestive Remedies , Paediatric Vitamins and Dietary Supplements .

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.